By Topic

In silico Ligand-Based (LB) and Docking-Based (DB) 3D-QSAR Study of Potent Chk2 Inhibitors

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
Pasha, F.A. ; Comput. Sci. Center, Korea Inst. of Sci. & Technol., Seoul ; Muddassar, M. ; So Ha Lee ; Taebo Sim
more authors

Isothiazole carboxamidine compounds are potent ATP competitive Chk2 inhibitors. A series of compounds with Chk2 inhibitory activity were taken from literature and different 3D-QSAR models have been generated with Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). In first scheme LB-QSAR models were generated using fully optimized geometries by PM3 approach giving reasonable statistics of CoMFA (q2= 0.88, r2 = 0.96 and r2 predictive = 0.60) and CoMSIA(q2 = 0.918 r2 = 0.99 and r2 predictive = 0.55). In second and third scheme the ligands 7 docked in to receptor protein (PDB 2CN8). Consequently, two most plausible modes were identified and used as initial templates. The docked conformer based CoMFA model shows good correlation with activity (q2 = 0.91, r2 = 0.99 and r2 predictive = 0.84). Whereas in CoMSIA, the steric and hydrophobic and donor field jointly give a better statistics (q2 =0.92 r2 = 0.99 and r2 predictive =0.53). These findings might be helpful to design more potent Chk2 inhibitors.

Published in:

Frontiers in the Convergence of Bioscience and Information Technologies, 2007. FBIT 2007

Date of Conference:

11-13 Oct. 2007